Simplexa VZV Direct, Simplexa VZV Positive Control Pack— 510(k) K190219

Substantially Equivalent

Diasorin Molecular, LLC

FDA 510(k) clearance K190219 for Simplexa VZV Direct, Simplexa VZV Positive Control Pack, Substantially Equivalent on 2019-05-13. Applicant: Diasorin Molecular, LLC.

Clearance details

Applicant
Diasorin Molecular, LLC
Product code
Code PLO
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Cypress, CA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code PLO

product code PLO
Death
5
Total
5

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.